Friess Associates’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-959,274
Closed -$15.4M 172
2014
Q2
$15.4M Buy
959,274
+159,274
+20% +$2.48M 1.25% 39
2014
Q1
$14.4M Buy
+800,000
New +$13.8M 1.13% 46

Other funds holding MDRX

Friess Associates's MDRX Position: Q3 2014 in Review

Friess Associates sold out of Veradigm Inc. Common Stock (MDRX) in Q3 2014, closing a stake of 959,274 shares — an estimated $15.4M sold.

Friess Associates first reported a position in MDRX in Q1 2014 and held it in 2 quarters. The position peaked at $15.4M in Q2 2014. 225 funds tracked by Wall St. Rank hold MDRX as of Q3 2014.

  • Friess Associates reported no remaining Veradigm Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
  • Friess Associates sold 959,274 Veradigm Inc. Common Stock shares in Q3 2014, an estimated $15.4M.
  • Friess Associates first reported a position in Veradigm Inc. Common Stock in Q1 2014 and held it in 2 quarters.
  • Friess Associates's Veradigm Inc. Common Stock position peaked at $15.4M in Q2 2014.
  • 225 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q3 2014.

Based on Friess Associates's 13F filing for Q3 2014, filed 14 Nov 2014.